| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Internal Medicine, Division of Rheumatology (C.G., N.P.), Division of Endocrinology and Diabetes (M.G.D., C.A.M.), and Division of Immunology and Allergy (R.C.), University Hospital Geneva, CH-1211 Geneva, Switzerland
Address correspondence and requests for reprints to: Dr. Christoph A. Meier, Division of Endocrinology and Diabetes, University Hospital Geneva, 24, rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. E-mail: cameier{at}bluewin.ch
Besides its actions on the regulation of appetite, leptin has also been
implicated in regulating reproductive and immune functions. Because
leptin-deficient mice are more susceptible to lipopolysaccharide- and
tumor necrosis factor-
-induced shock, which is associated with lower
levels of interleukin 1 receptor antagonist (IL-1Ra), we investigated
whether leptin is a direct regulator of IL-1Ra in human monocytes. In
human moncytic cells, leptin was capable of inducing a 6- to 10-fold
increase in secreted IL-1Ra in a time- and dose-dependent manner.
Moreover, leptin induced the messenger RNA for IL-1Ra within 8 h
and specifically activated the promoter for this gene. However, leptin
had no effect on the expression or secretion of IL-1 in THP-1 cells.
This effect of leptin on monocytic cells requires the presence of the
functional leptin receptor OB-Rb, which we have shown to be present in
human monocytes by RT-PCR and by measuring the activation of the
Jak/STAT pathway.
In summary, we have demonstrated that leptin is capable of inducing the expression and secretion of IL-1Ra by human monocytes, an effect that is potentially mediated through the presence of functional leptin receptors on these cells. These findings suggest that leptin may have immunomodulatory functions in vivo.
This article has been cited by other articles:
![]() |
D. Gaucher, R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali-Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake III, E. Castro, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses J. Exp. Med., December 22, 2008; 205(13): 3119 - 3131. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thalmann and C. A. Meier Local adipose tissue depots as cardiovascular risk factors Cardiovasc Res, September 1, 2007; 75(4): 690 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Oral, E. D. Javor, L. Ding, G. Uzel, E. K. Cochran, J. R. Young, A. M. DePaoli, S. M. Holland, and P. Gorden Leptin Replacement Therapy Modulates Circulating Lymphocyte Subsets and Cytokine Responsiveness in Severe Lipodystrophy J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 621 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Martin, R. de Vittoris, V. David, R. Moraes, M. Begeot, M.-H. Lafage-Proust, C. Alexandre, L. Vico, and T. Thomas Leptin Modulates both Resorption and Formation while Preventing Disuse-Induced Bone Loss in Tail-Suspended Female Rats Endocrinology, August 1, 2005; 146(8): 3652 - 3659. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Molnarfi, N. Hyka-Nouspikel, L. Gruaz, J.-M. Dayer, and D. Burger The Production of IL-1 Receptor Antagonist in IFN-{beta}-Stimulated Human Monocytes Depends on the Activation of Phosphatidylinositol 3-Kinase but Not of STAT1 J. Immunol., March 1, 2005; 174(5): 2974 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Bullen Jr, M. Ziotopoulou, L. Ungsunan, J. Misra, I. Alevizos, E. Kokkotou, E. Maratos-Flier, G. Stephanopoulos, and C. S. Mantzoros Short-term resistance to diet-induced obesity in A/J mice is not associated with regulation of hypothalamic neuropeptides Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E662 - E670. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ottonello, P. Gnerre, M. Bertolotto, M. Mancini, P. Dapino, R. Russo, G. Garibotto, T. Barreca, and F. Dallegri Leptin as a Uremic Toxin Interferes with Neutrophil Chemotaxis J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2366 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Juge-Aubry, E. Somm, R. Chicheportiche, D. Burger, A. Pernin, B. Cuenod-Pittet, P. Quinodoz, V. Giusti, J.-M. Dayer, and C. A. Meier Regulatory Effects of Interleukin (IL)-1, Interferon-{beta}, and IL-4 on the Production of IL-1 Receptor Antagonist by Human Adipose Tissue J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2652 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maedler, P. Sergeev, J. A. Ehses, Z. Mathe, D. Bosco, T. Berney, J.-M. Dayer, M. Reinecke, P. A. Halban, and M. Y. Donath Leptin modulates {beta} cell expression of IL-1 receptor antagonist and release of IL-1{beta} in human islets PNAS, May 25, 2004; 101(21): 8138 - 8143. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gaige, E. Abou, A. Abysique, and M. Bouvier Effects of interactions between interleukin-1{beta} and leptin on cat intestinal vagal mechanoreceptors J. Physiol., February 15, 2004; 555(1): 297 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zarkesh-Esfahani, A. G. Pockley, Z. Wu, P. G. Hellewell, A. P. Weetman, and R. J. M. Ross Leptin Indirectly Activates Human Neutrophils via Induction of TNF-{alpha} J. Immunol., February 1, 2004; 172(3): 1809 - 1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Ryan, K. H. Van der Hoek, S. A. Robertson, and R. J. Norman Leptin and Leptin Receptor Expression in the Rat Ovary Endocrinology, November 1, 2003; 144(11): 5006 - 5013. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Xiao, L. Xia-Zhang, N. R. Vulliemoz, M. Ferin, and S. L. Wardlaw Leptin Modulates Inflammatory Cytokine and Neuroendocrine Responses to Endotoxin in the Primate Endocrinology, October 1, 2003; 144(10): 4350 - 4353. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Palmer and C Gabay A role for leptin in rheumatic diseases? Ann Rheum Dis, October 1, 2003; 62(10): 913 - 915. [Full Text] |
||||
![]() |
M Bokarewa, D Bokarew, O Hultgren, and A Tarkowski Leptin consumption in the inflamed joints of patients with rheumatoid arthritis Ann Rheum Dis, October 1, 2003; 62(10): 952 - 956. [Abstract] [Full Text] |
||||
![]() |
C. E. Juge-Aubry, E. Somm, V. Giusti, A. Pernin, R. Chicheportiche, C. Verdumo, F. Rohner-Jeanrenaud, D. Burger, J.-M. Dayer, and C. A. Meier Adipose Tissue Is a Major Source of Interleukin-1 Receptor Antagonist: Upregulation in Obesity and Inflammation Diabetes, May 1, 2003; 52(5): 1104 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueland, C. Kristo, K. Godang, P. Aukrust, and J. Bollerslev Interleukin-1 Receptor Antagonist Is Associated with Fat Distribution in Endogenous Cushing's Syndrome: A Longitudinal Study J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1492 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Gonzalez, K. Leary, J. C. Petrozza, and P. C. Leavis Leptin regulation of the interleukin-1 system in human endometrial cells Mol. Hum. Reprod., March 1, 2003; 9(3): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Meier, E. Bobbioni, C. Gabay, F. Assimacopoulos-Jeannet, A. Golay, and J.-M. Dayer IL-1 Receptor Antagonist Serum Levels Are Increased in Human Obesity: A Possible Link to the Resistance to Leptin? J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1184 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Busso, A. So, V. Chobaz-Peclat, C. Morard, E. Martinez-Soria, D. Talabot-Ayer, and C. Gabay Leptin Signaling Deficiency Impairs Humoral and Cellular Immune Responses and Attenuates Experimental Arthritis J. Immunol., January 15, 2002; 168(2): 875 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. FAGGIONI, K. R. FEINGOLD, and C. GRUNFELD Leptin regulation of the immune response and the immunodeficiency of malnutrition FASEB J, December 1, 2001; 15(14): 2565 - 2571. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |